Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1867011587191078912 |
|---|---|
| author | Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu |
| author_facet | Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu |
| collection | Wiley Open Access |
| contents | Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu International Journal of Dermatology ABSTRACT Background Proteolytic enzymes, including matrix metalloproteinase‐9 (MMP‐9) and granzyme B, contribute to dermal–epidermal separation, but their expression in human skin lesions is not fully quantified. We aimed to quantify tissue levels of MMP‐9 and granzyme B in bullous pemphigoid (BP) lesional skin compared to healthy controls. Methods In a case–control study at the National Hospital of Dermatology and Venereology in Hanoi, Vietnam, between June 2024 and June 2025, lesional skin from BP patients and normal skin from healthy controls were analyzed. Matrix metalloproteinase‐9 (MMP‐9) and granzyme B levels were quantified using enzyme‐linked immunosorbent assay (ELISA). Mann–Whitney U tests, linear regression, and receiver operating characteristic (ROC) analyses were conducted to assess group differences, clinical associations, and diagnostic performance. Results Forty‐eight BP patients and 21 healthy controls were included in our study. The median level of MMP‐9 was 216.4 pg/mL/mg (interquartile range [IQR]: 74.6–570.0) in BP patients vs. 58.7 pg/mL/mg (IQR: 16.6–154.2) in controls ( p = 0.0031). Granzyme B level was 2.16 pg/mL/mg (IQR: 1.26–5.13) in BP patients compared to 0.40 pg/mL/mg (IQR: 0.19–1.67) in the control group ( p < 0.0001). ROC analysis showed areas under the curve (AUCs) of 0.722 for MMP‐9 and 0.781 for granzyme B, while the combined model reached 0.799. MMP‐9 level was correlated with body weight ( r = 0.32, p = 0.023) and leukocyte counts ( r = 0.29, p = 0.037), whereas granzyme B level was correlated with disease duration ( r = 0.30, p = 0.032). Conclusions Our study underscores that tissue levels of MMP‐9 and granzyme B are significantly heightened compared to healthy controls. These proteases play a pivotal role in all types of skin lesions and reflect the local activity of BP. 10.1111/ijd.70310 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1111/ijd.70310 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_ijd_70310 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu International Journal of Dermatology Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study Hoa Dinh Pham Doanh Huu Le Tung Son Tran Son Duc Le Sho Hiroyasu An Thi Vinh Do Giang Thi Ha Quach Daisuke Tsuruta Lan Thi Pham Luong Huy Vu International Journal of Dermatology ABSTRACT Background Proteolytic enzymes, including matrix metalloproteinase‐9 (MMP‐9) and granzyme B, contribute to dermal–epidermal separation, but their expression in human skin lesions is not fully quantified. We aimed to quantify tissue levels of MMP‐9 and granzyme B in bullous pemphigoid (BP) lesional skin compared to healthy controls. Methods In a case–control study at the National Hospital of Dermatology and Venereology in Hanoi, Vietnam, between June 2024 and June 2025, lesional skin from BP patients and normal skin from healthy controls were analyzed. Matrix metalloproteinase‐9 (MMP‐9) and granzyme B levels were quantified using enzyme‐linked immunosorbent assay (ELISA). Mann–Whitney U tests, linear regression, and receiver operating characteristic (ROC) analyses were conducted to assess group differences, clinical associations, and diagnostic performance. Results Forty‐eight BP patients and 21 healthy controls were included in our study. The median level of MMP‐9 was 216.4 pg/mL/mg (interquartile range [IQR]: 74.6–570.0) in BP patients vs. 58.7 pg/mL/mg (IQR: 16.6–154.2) in controls ( p = 0.0031). Granzyme B level was 2.16 pg/mL/mg (IQR: 1.26–5.13) in BP patients compared to 0.40 pg/mL/mg (IQR: 0.19–1.67) in the control group ( p < 0.0001). ROC analysis showed areas under the curve (AUCs) of 0.722 for MMP‐9 and 0.781 for granzyme B, while the combined model reached 0.799. MMP‐9 level was correlated with body weight ( r = 0.32, p = 0.023) and leukocyte counts ( r = 0.29, p = 0.037), whereas granzyme B level was correlated with disease duration ( r = 0.30, p = 0.032). Conclusions Our study underscores that tissue levels of MMP‐9 and granzyme B are significantly heightened compared to healthy controls. These proteases play a pivotal role in all types of skin lesions and reflect the local activity of BP. 10.1111/ijd.70310 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Tissue Levels of MMP‐9 and Granzyme B in Patients With Bullous Pemphigoid: A Case–Control Study |
| topic | International Journal of Dermatology |
| url | https://onlinelibrary.wiley.com/doi/10.1111/ijd.70310 |